Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Ophthalmology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
ASH 2024 Annual Meeting 2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on adolescent vaping

LIVE: Wednesday 29th January, 18:00-19:30 CET

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?
ADVANCED SEARCH
Log in
Top
Current Psychiatry Reports
Published in:

09-07-2022 | Mood Disorders | Geriatric Disorders (JA Cheong, Section Editors)

HIV and AIDS in Older Adults: Neuropsychiatric Changes

Authors: Paroma Mitra, Ankit Jain, Katherine Kim

Published in: Current Psychiatry Reports | Issue 9/2022

Login to get access

Abstract

Purpose of Review

Patients diagnosed with HIV can now survive well into their old age. Aging with HIV is not only associated with comorbid medical illnesses but also with neuropsychiatric conditions that can range from cognitive changes to severe behavioral manifestations. This paper reviews mood, anxiety, and cognitive changes in older patients with HIV, as well as some of the treatment challenges in this population.

Recent Findings

Most recent findings show that untreated HIV illness over a long period of time may further worsen both preexisting neuropsychiatric illness and may cause new onset behavioral and cognitive symptoms. HIV induces immune phenotypic changes that have been compared to accelerated aging Low CD 4 counts and high viral counts are indicative of poor prognosis.

Summary

Evaluation for potential HIV infections may be overlooked in older adults and require screening. Older adults experience accelerated CD4 cell loss. Older adults endorsing new onset mood or cognitive changes must be screened for HIV infection. New onset neurobehavioral symptoms should be carefully screened for and treated simultaneously in patients with HIV infection.
Literature
1.
2.
3.
Stoskopf CH, Kim YK, Glover SH. Dual diagnosis: HIV and mental illness, a population-based study. Community Ment Health J. 2001;37(6):469–79.PubMedCrossRef
4.
Steves CJ, Spector TD, Jackson SHD. Ageing, genes, environment and epigenetics: what twin studies tell us now, and in the future. Age Ageing. 2012;41(5):581–6.PubMedCrossRef
5.
Vasto S, Scapagnini G, Bulati M, Candore G, Castiglia L, Colonna-Romano G, et al. Biomarkes of aging. Front Biosci Sch Ed. 2010;1(2):392–402.
6.
•• Watkins CC, Treisman GJ. Neuropsychiatric complications of aging with HIV. J NeuroVirol. 2012;18. This is an important paper- given that it summarizes the impact of aging on persons with HIV and also summarizes impact on both psychiatric illness that preexisted before HIV was detected and after.
7.
Effros RB, Fletcher CV, Gebo K, Halter JB, Hazzard WR, Horne FM, et al. Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis. 2008;47(4):542–53.PubMedCrossRef
8.
Havlik RJ, Brennan M, Karpiak SE. Comorbidities and depression in older adults with HIV. Sex Health. 2011;8(4):551.PubMedCrossRef
9.
Valcour V, Shikuma C, Shiramizu B, Watters M, Poff P, Selnes O, et al. Higher frequency of dementia in older HIV-1 individuals: the Hawaii aging with HIV-1 cohort. Neurology. 2004;63(5):822–7.PubMedCrossRef
10.
Balderson BH, Grothaus L, Harrison RG, McCoy K, Mahoney C, Catz S. Chronic illness burden and quality of life in an aging HIV population. AIDS Care. 2013;25(4):451–8.PubMedCrossRef
11.
Kilbourne AM, Justice AC, Rabeneck L, Rodriguez-Barradas M, Weissman S. General medical and psychiatric comorbidity among HIV-infected veterans in the post-HAART era. J Clin Epidemiol. 2001;54(12):S22–8.PubMedCrossRef
12.
Oursler KK, Goulet JL, Crystal S, Justice AC, Crothers K, Butt AA, et al. Association of age and comorbidity with physical function in HIV-infected and uninfected patients: results from the veterans aging cohort study. AIDS Patient Care STDs. 2011;25(1):13–20.PubMedPubMedCentralCrossRef
13.
Rodriguez-Penney AT, Iudicello JE, Riggs PK, Doyle K, Ellis RJ, Letendre SL, et al. Co-morbidities in persons infected with HIV: increased burden with older age and negative effects on health-related quality of life. AIDS Patient Care STDs. 2013;27(1):5–16.PubMedPubMedCentralCrossRef
14.
Angelino AF, Treisman GJ. Issues in co-morbid severe mental illnesses in HIV infected individuals. Int Rev Psychiatry. 2008;20(1):95–101.PubMedCrossRef
15.
16.
17.
Siegel K, Bradley CJ, Lekas H-M. Causal attributions for fatigue among late middle-aged and older adults with HIV infection. J Pain Symptom Manage. 2004;28(3):211–24.PubMedCrossRef
18.
Penzak SR, Reddy YS, Grimsley SR. Depression in patients with HIV infection. Am J Health Syst Pharm. 2000;57(4):376–86.PubMedCrossRef
19.
20.
Kalichman SC, Heckman T, Kochman A, Sikkema K, Bergholte J. Depression and thoughts of suicide among middle-aged and older persons living with HIV-AIDS. Psychiatr Serv. 2000;51(7):903–7.PubMedCrossRef
21.
Kalichman SC, Rompa D, Cage M. Distinguishing between overlapping somatic symptoms of depression and HIV disease in people living with HIV-AIDS: J Nerv Ment Dis. 2000;188(10):662–70.PubMed
22.
Gutkovich Z, Rosenthal RN, Galynker I, Muran C, Batchelder S, Itskhoki E. Depression and demoralization among Russian-Jewish immigrants in primary care. Psychosomatics. 1999;40(2):117–25.PubMedCrossRef
23.
Clarke DM, Kissane DW. Demoralization: its phenomenology and importance. Aust N Z J Psychiatry. 2002;36(6):733–42.PubMedCrossRef
24.
•• Leserman J. HIV disease progression: depression, stress, and possible mechanisms. Biol Psychiatry. 2003;54(3):295–306. This is an important paper as it is the first to detail the effect of HIV on depression as well as the neurobiology of the same.PubMedCrossRef
25.
Ammassari A, Antinori A, Aloisi MS, Trotta MP, Murri R, Bartoli L, et al. Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics. 2004;45(5):394–402.PubMedCrossRef
26.
Lyketsos CG, Treisman GJ. Mood disorders in HIV infection. Psychiatr Ann. 2001;31(1):45–9.CrossRef
27.
Cooperman NA, Simoni JM. Suicidal ideation and attempted suicide among women living with HIV/AIDS. J Behav Med. 2005;28(2):149–56.PubMedCrossRef
28.
Pence BW, Gaynes BN, Adams JL, Thielman NM, Heine AD, Mugavero MJ, et al. The effect of antidepressant treatment on HIV and depression outcomes: results from a randomized trial. AIDS. 2015;29(15):1975–86.PubMedCrossRef
29.
Stockton MA, Udedi M, Kulisewa K, Hosseinipour MC, Gaynes BN, Mphonda SM, et al. The impact of an integrated depression and HIV treatment program on mental health and HIV care outcomes among people newly initiating antiretroviral therapy in Malawi. Torpey K, editor. PLoS ONE. 2020;15(5):e0231872.
30.
Hinkin CH, Castellon SA, Hardy DJ, Farinpour R, Newton T, Singer E. Methylphenidate Improves HIV-1–associated cognitive slowing. J Neuropsychiatry Clin Neurosci. 2001;13(2):248–54.PubMedCrossRef
31.
Nakimuli-Mpungu E, Musisi S, Kiwuwa Mpungu S, Katabira E. Clinical presentation of bipolar mania in HIV-positive patients in Uganda. Psychosomatics. 2009;50(4):325–30.PubMedCrossRef
32.
Lyketsos CG, Schwartz J, Fishman M, Treisman G. AIDS mania. J Neuropsychiatry Clin Neurosci. 1997;9(2):277–9.PubMedCrossRef
33.
Marinho M, Marques J, Bragança M. Aids mania – is it a potential indicator to initiate HAART? Eur Psychiatry. 2016;33(S1):S526–7.
34.
• Kalichman SC, Kelly JA, Johnson JR, Bulto M. Factors associated with risk for HIV infection among chronic mentally ill adults. Am J Psychiatry. 1994;151(2):221–7. This is a relevant paper as it address the impact of HIV infection on persons with severe persistent mental illness.PubMedCrossRef
35.
Blank MB, Himelhoch S, Walkup J, Eisenberg MM. Treatment considerations for HIV-infected individuals with severe mental illness. Curr HIV/AIDS Rep. 2013;10(4):371–9.PubMedCrossRef
36.
Nurutdinova D, Chrusciel T, Zeringue A, Scherrer JF, Al-Aly Z, McDonald JR, et al. Mental health disorders and the risk of AIDS-defining illness and death in HIV-infected veterans. AIDS. 2012;26(2):229–34.PubMedCrossRef
37.
Dolder CR, Patterson TL, Jeste DV. HIV, psychosis and aging: past, present and future. AIDS Lond Engl. 2004;1(18 Suppl 1):S35-42.CrossRef
38.
Hriso E, Kuhn T, Masdeu JC, Grundman M. Extrapyramidal symptoms due to dopamine-blocking agents in patients with AIDS encephalopathy. Am J Psychiatry. 1991;148(11):1558–61.PubMedCrossRef
39.
Brandt C, Zvolensky MJ, Woods SP, Gonzalez A, Safren SA, O’Cleirigh CM. Anxiety symptoms and disorders among adults living with HIV and AIDS: a critical review and integrative synthesis of the empirical literature. Clin Psychol Rev. 2017;51:164–84.PubMedCrossRef
40.
Morrison MF, Petitto JM, Have TT, Gettes DR, Chiappini MS, Weber AL, et al. Depressive and anxiety disorders in women with HIV infection. Am J Psychiatry. 2002;159(5):789–96.PubMedCrossRef
41.
42.
Navia BA, Price RW. The acquired immunodeficiency syndrome dementia complex as the presenting or sole manifestation of human immunodeficiency virus infection. Arch Neurol. 1987;44(1):65–9.PubMedCrossRef
43.
Stern Y. Factors associated with incident human immunodeficiency virus–dementia. Arch Neurol. 2001;58(3):473.PubMedCrossRef
44.
•• Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69(18):1789–99. This is an important paper that addresses the current breakdown of neurocognitive disorders in HIV with staging.PubMedCrossRef
45.
Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011;17(1):3–16.PubMedCrossRef
46.
Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features Ann Neurol. 1986;19(6):517–24.PubMedCrossRef
47.
Eggers C, Arendt G, Hahn K, Husstedt IW, Maschke M, Neuen-Jacob E, et al. HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment. J Neurol. 2017;264(8):1715–27.PubMedPubMedCentralCrossRef
48.
49.
Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment: MOCA: A brief screening tool for MCI. J Am Geriatr Soc. 2005;53(4):695–9.
50.
Power C, Selnes OA, Grim JA, McArthur JC. HIV dementia scale: a rapid screening test: J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8(3):273–8.PubMedCrossRef
51.
Tozzi V, Balestra P, Bellagamba R, Corpolongo A, Salvatori MF, Visco-Comandini U, et al. Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. JAIDS J Acquir Immune Defic Syndr. 2007;45(2):174–82.PubMedCrossRef
52.
Letendre S. Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol. 2008;65(1):65.PubMedPubMedCentralCrossRef
53.
•• The Mind Exchange Working Group, Antinori A, Arendt G, Grant I, Letendre S, Chair, et al. Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program. Clin Infect Dis. 2013;56(7):1004–17. This is an important paper as this group continually works on neurocognitive symptoms seen in HIV and updates their information.
54.
Levy BR, Ding L, Lakra D, Kosteas J, Niccolai L. Older persons’ exclusion from sexually transmitted disease risk-reduction clinical trials. Sex Transm Dis. 2007;34(8):541–4.PubMedCrossRef
55.
Levy JA, Ory MG, Crystal S. HIV/AIDS interventions for midlife and older adults: current status and challenges. JAIDS J Acquir Immune Defic Syndr. 2003;33(Sup 2):S59–67.
56.
Deeks SG, Phillips AN. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ. 2009;338(jan26 2):a3172–a3172.
57.
•• Work Group for HIV and Aging Consensus Project. Summary report from the human immunodeficiency virus and aging consensus project: treatment strategies for clinicians managing older individuals with the human immunodeficiency virus. J Am Geriatr Soc. 2012;60(5):974–9. This is another group that continues to address the overall effect of HIV on older individuals and gives treatment guidelines.CrossRef
58.
Kenedi CA, Goforth HW. A systematic review of the psychiatric side-effects of efavirenz. AIDS Behav. 2011;15(8):1803–18.PubMedCrossRef
59.
Lochet P, Peyriere H, Lotthe A, Mauboussin J, Delmas B, Reynes J. Long-term assessment of neuropsychiatric adverse reactions associated with efavirenz. HIV Med. 2003;4(1):62–6.PubMedCrossRef
60.
Gutiérrez-Valencia A. Stepped-Dose versus full-dose efavirenz for HIV infection and neuropsychiatric adverse events: a randomized trial. Ann Intern Med. 2009;151(3):149.PubMedCrossRef
61.
Hoffmann C, Llibre JM. Neuropsychiatric adverse events with dolutegravir and other integrase strand transfer inhibitors. Aids Rev. 2019;21(1):1768.CrossRef
62.
Thompson A, Silverman B, Dzeng L, Treisman G. Psychotropic medications and HIV. Clin Infect Dis. 2006;42(9):1305–10.PubMedCrossRef
Metadata
Title
HIV and AIDS in Older Adults: Neuropsychiatric Changes
Authors
Paroma Mitra
Ankit Jain
Katherine Kim
Publication date
09-07-2022
Publisher
Springer US
Published in
Current Psychiatry Reports / Issue 9/2022
Print ISSN: 1523-3812
Electronic ISSN: 1535-1645
DOI
https://doi.org/10.1007/s11920-022-01354-z

Other articles of this Issue 9/2022

Telehealth-Based Delivery of Medication-Assisted Treatment for Opioid Use Disorder: a Critical Review of Recent Developments

  • COVID-19
  • Psychiatry in the Digital Age (J Shore, Section Editor)

Addressing the Behavioral Health Needs of Sexual and Gender Minorities During the COVID-19 Pandemic: a Review of the Expanding Role of Digital Health Technologies

  • COVID-19
  • Psychiatry in the Digital Age (J Shore, Section Editor)

Technology-Based Approaches for Supporting Perinatal Mental Health

  • Care
  • Psychiatry in the Digital Age (J Shore, Section Editor)

Managing Behavioral and Psychological Symptoms of Dementia (BPSD) in the Era of Boxed Warnings

Complementary and Integrative Medicine for Neurocognitive Disorders and Caregiver Health

Adapting and Implementing Apps for Mental Healthcare

  • Care
  • Psychiatry in the Digital Age (J Shore, Section Editor)